Ethiopia

Ethiopia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.84 (3.31 - 4.43) 2019 Modelled IHME
3.91 (3.37 - 4.52) 2018 Modelled IHME
3.94 (3.38 - 4.57) 2017 Modelled IHME
3.93 (3.40 - 4.54) 2016 Modelled IHME
3.92 (3.39 - 4.53) 2015 Modelled IHME
3.96 (3.43 - 4.57) 2014 Modelled IHME
4.07 (3.53 - 4.67) 2013 Modelled IHME
4.21 (3.64 - 4.84) 2012 Modelled IHME
4.36 (3.79 - 5.01) 2011 Modelled IHME
4.49 (3.91 - 5.16) 2010 Modelled IHME
4.61 (4.02 - 5.29) 2009 Modelled IHME
4.73 (4.13 - 5.45) 2008 Modelled IHME
4.85 (4.24 - 5.59) 2007 Modelled IHME
4.96 (4.33 - 5.72) 2006 Modelled IHME
5.04 (4.39 - 5.81) 2005 Modelled IHME
5.11 (4.45 - 5.89) 2004 Modelled IHME
5.18 (4.50 - 5.95) 2003 Modelled IHME
5.24 (4.55 - 6.02) 2002 Modelled IHME
5.28 (4.55 - 6.08) 2001 Modelled IHME
5.32 (4.58 - 6.12) 2000 Modelled IHME
5.34 (4.60 - 6.14) 1999 Modelled IHME
5.35 (4.62 - 6.15) 1998 Modelled IHME
5.37 (4.64 - 6.18) 1997 Modelled IHME
5.38 (4.65 - 6.20) 1996 Modelled IHME
5.39 (4.66 - 6.22) 1995 Modelled IHME
5.41 (4.68 - 6.24) 1994 Modelled IHME
5.43 (4.69 - 6.28) 1993 Modelled IHME
5.44 (4.71 - 6.30) 1992 Modelled IHME
5.46 (4.72 - 6.32) 1991 Modelled IHME
5.47 (4.71 - 6.35) 1990 Modelled IHME
5.68 (4.72 - 6.82) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.32 (1.06 - 1.63) 2019 Modelled IHME
1.43 (1.15 - 1.76) 2018 Modelled IHME
1.48 (1.18 - 1.83) 2017 Modelled IHME
1.48 (1.19 - 1.82) 2016 Modelled IHME
1.49 (1.19 - 1.82) 2015 Modelled IHME
1.51 (1.22 - 1.85) 2014 Modelled IHME
1.57 (1.27 - 1.93) 2013 Modelled IHME
1.66 (1.34 - 2.04) 2012 Modelled IHME
1.77 (1.44 - 2.19) 2011 Modelled IHME
1.9 (1.54 - 2.35) 2010 Modelled IHME
2.13 (1.73 - 2.62) 2009 Modelled IHME
2.49 (2.03 - 3.06) 2008 Modelled IHME
2.88 (2.35 - 3.52) 2007 Modelled IHME
3.22 (2.62 - 3.93) 2006 Modelled IHME
3.4 (2.75 - 4.15) 2005 Modelled IHME
3.45 (2.79 - 4.22) 2004 Modelled IHME
3.5 (2.81 - 4.27) 2003 Modelled IHME
3.53 (2.83 - 4.31) 2002 Modelled IHME
3.55 (2.85 - 4.35) 2001 Modelled IHME
3.57 (2.87 - 4.37) 2000 Modelled IHME
3.59 (2.90 - 4.39) 1999 Modelled IHME
3.6 (2.92 - 4.40) 1998 Modelled IHME
3.61 (2.93 - 4.42) 1997 Modelled IHME
3.62 (2.94 - 4.43) 1996 Modelled IHME
3.63 (2.96 - 4.44) 1995 Modelled IHME
3.64 (2.96 - 4.47) 1994 Modelled IHME
3.65 (2.96 - 4.47) 1993 Modelled IHME
3.66 (2.98 - 4.48) 1992 Modelled IHME
3.67 (2.98 - 4.50) 1991 Modelled IHME
3.67 (2.98 - 4.52) 1990 Modelled IHME
2.61 (1.90 - 3.37) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
22 (19 - 26) 2019 Modelled IHME
22 (19 - 26) 2018 Modelled IHME
22 (19 - 26) 2017 Modelled IHME
23 (20 - 26) 2016 Modelled IHME
23 (20 - 26) 2015 Modelled IHME
23 (20 - 26) 2014 Modelled IHME
23 (20 - 26) 2013 Modelled IHME
23 (19 - 26) 2012 Modelled IHME
22 (19 - 26) 2011 Modelled IHME
22 (19 - 26) 2010 Modelled IHME
22 (19 - 26) 2009 Modelled IHME
23 (19 - 26) 2008 Modelled IHME
23 (20 - 26) 2007 Modelled IHME
23 (20 - 26) 2006 Modelled IHME
23 (20 - 26) 2005 Modelled IHME
23 (20 - 27) 2004 Modelled IHME
23 (20 - 27) 2003 Modelled IHME
23 (20 - 26) 2002 Modelled IHME
23 (20 - 27) 2001 Modelled IHME
23 (20 - 27) 2000 Modelled IHME
23 (20 - 27) 1999 Modelled IHME
23 (20 - 27) 1998 Modelled IHME
23 (20 - 27) 1997 Modelled IHME
24 (20 - 27) 1996 Modelled IHME
23 (20 - 27) 1995 Modelled IHME
23 (20 - 27) 1994 Modelled IHME
23 (20 - 27) 1993 Modelled IHME
23 (20 - 27) 1992 Modelled IHME
23 (20 - 27) 1991 Modelled IHME
23 (20 - 27) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
72 2018 Survey/reported WHO/UNICEF
73 2017 Survey/reported WHO/UNICEF
73 2016 Survey/reported WHO/UNICEF
73 2015 Survey/reported WHO/UNICEF
61 2014 Survey/reported WHO/UNICEF
59 2013 Survey/reported WHO/UNICEF
62 2012 Survey/reported WHO/UNICEF
65 2011 Survey/reported WHO/UNICEF
62 2010 Survey/reported WHO/UNICEF
56 2009 Survey/reported WHO/UNICEF
52 2008 Survey/reported WHO/UNICEF
47 2007 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2020
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
No
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.6 (1.28 - 2.02) 2019 Modelled IHME
1.6 (1.28 - 2.02) 2018 Modelled IHME
1.6 (1.27 - 2.01) 2017 Modelled IHME
1.6 (1.28 - 2.01) 2016 Modelled IHME
1.6 (1.28 - 2.01) 2015 Modelled IHME
1.6 (1.28 - 2) 2014 Modelled IHME
1.6 (1.28 - 2.01) 2013 Modelled IHME
1.61 (1.29 - 2) 2012 Modelled IHME
1.61 (1.29 - 2.01) 2011 Modelled IHME
1.61 (1.29 - 2.01) 2010 Modelled IHME
1.63 (1.31 - 2.03) 2009 Modelled IHME
1.66 (1.34 - 2.07) 2008 Modelled IHME
1.71 (1.37 - 2.13) 2007 Modelled IHME
1.75 (1.40 - 2.18) 2006 Modelled IHME
1.78 (1.43 - 2.22) 2005 Modelled IHME
1.8 (1.45 - 2.25) 2004 Modelled IHME
1.82 (1.46 - 2.28) 2003 Modelled IHME
1.84 (1.47 - 2.31) 2002 Modelled IHME
1.85 (1.48 - 2.33) 2001 Modelled IHME
1.86 (1.48 - 2.34) 2000 Modelled IHME
1.85 (1.48 - 2.34) 1999 Modelled IHME
1.85 (1.48 - 2.32) 1998 Modelled IHME
1.84 (1.47 - 2.31) 1997 Modelled IHME
1.83 (1.46 - 2.29) 1996 Modelled IHME
1.83 (1.46 - 2.29) 1995 Modelled IHME
1.83 (1.47 - 2.30) 1994 Modelled IHME
1.84 (1.47 - 2.31) 1993 Modelled IHME
1.86 (1.48 - 2.34) 1992 Modelled IHME
1.88 (1.49 - 2.37) 1991 Modelled IHME
1.9 (1.51 - 2.42) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.3 (0.70 - 5.80) 2014 Modelled Gower et al, 2014

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
34 (31 - 38) 2019 Modelled IHME
34 (30 - 38) 2018 Modelled IHME
34 (30 - 38) 2017 Modelled IHME
34 (30 - 37) 2016 Modelled IHME
33 (29 - 37) 2015 Modelled IHME
33 (29 - 37) 2014 Modelled IHME
33 (29 - 37) 2013 Modelled IHME
33 (29 - 37) 2012 Modelled IHME
33 (29 - 36) 2011 Modelled IHME
32 (29 - 36) 2010 Modelled IHME
32 (28 - 36) 2009 Modelled IHME
32 (28 - 36) 2008 Modelled IHME
32 (28 - 35) 2007 Modelled IHME
31 (28 - 35) 2006 Modelled IHME
31 (27 - 35) 2005 Modelled IHME
31 (27 - 35) 2004 Modelled IHME
31 (27 - 35) 2003 Modelled IHME
31 (27 - 35) 2002 Modelled IHME
31 (27 - 35) 2001 Modelled IHME
31 (27 - 35) 2000 Modelled IHME
31 (26 - 35) 1999 Modelled IHME
30 (26 - 35) 1998 Modelled IHME
30 (26 - 35) 1997 Modelled IHME
30 (26 - 35) 1996 Modelled IHME
30 (26 - 35) 1995 Modelled IHME
30 (26 - 35) 1994 Modelled IHME
30 (26 - 35) 1993 Modelled IHME
30 (26 - 35) 1992 Modelled IHME
30 (26 - 35) 1991 Modelled IHME
30 (26 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2020
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
No
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
3.84 (%)
2019
(3.31 - 4.43(%))
IHME
HCV (RNA/cAg+)
1.6 (%)
2019
(1.28 - 2.02(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
6,348
2019
(5,009 - 7,993)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
9,433
2019
(7,777 - 11,449)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
1.32 (%)
2019, latest modelled
(1.06 - 1.63(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines